Fresenius Medical Care is the world’s largest provider of products and services for people with chronic kidney failure. It manufactures dialysis machines, dialyzers and related disposables, and runs a global network of outpatient dialysis clinics. The integrated model—equipment plus clinic care—gives it scale across the full dialysis value chain for patients, nephrologists and payers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 4,791.7 | — | 225.3 | 9.4% |
| Q3 2025 | 4,884.9 | — | 274.8 | 13.8% |
| Q4 2025 | 5,069.6 | — | 327.1 | 19.3% |
| Q1 2026 | 4,612.1 | — | 117.5 | -52.3% |
| Q2 2026 | 4,860.6 | 1.4% | 218.4 | -3.1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: DICK'S Sporting Goods, Inc. (DKS), Smith & Nephew plc (SNN), American Healthcare REIT, Inc. (AHR), Hormel Foods Corporation (HRL), Rentokil Initial plc (RTO), Elanco Animal Health Incorporated (ELAN)